Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Medicine|May 17, 2018
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II studyGiandomenico Roviello, Roberto Petrioli, Valerio Nardone, et al.Cancer Chemotherapy and Pharmacology|January 26, 2015
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II studyRoberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, et al.Translational Oncology|May 30, 2020
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal CancerGiandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, et al.Anti-Cancer Drugs|June 9, 2015
Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II studyRoberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, et al.Cancer Letters|January 23, 2016
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancerGiandomenico Roviello, Andrea Ravelli, Karol Polom, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|December 17, 2015
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrenceKarol Polom, Luigi Marano, Giandomenico Roviello, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trialsGiandomenico Roviello, Thomas Bachelot, Clifford A Hudis, et al.Journal of Chemotherapy (Florence, Italy)|May 11, 2023
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabineAlberto D'Angelo, Martina Catalano, Raffaele Conca, et al.Cancer Chemotherapy and Pharmacology|October 3, 2002
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimensGuido Francini, Roberto Petrioli, Simona Messinese, et al.Anti-Cancer Drugs|January 28, 2026
The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitorsAlexandra Paulet, Silvia Mancini, Martina Catalano, et al.Pageof 11